The lower bioavailability actually works in favor here, as the body receives the active compound more gradually throughout the day rather than in a single bolus that can overwhelm GLP-1 receptors in the gut
3.Chen YQ, Pottanat TG, Siegel RW, Ehsani M, Qian Y, Zhen EY, Regmi A, Roell WC, Guo H, Luo MJ, Gimeno RE, van't Hooft F, Konrad RJ
Related Reading Key Genetic Factors And Effective Management For Improved Quality Of Life Semaglutide Genetics Weight Management Weight Management Semaglutide Tcf7L2 Rs7903146 Weight Management Semaglutide Pparg Rs1801282 Medical and Editorial Standards Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims
Ozempic Is About to Be Old News [Internet]
Literature was sourced from ClinicalTrials.gov and relevant scientific databases to compare tirzepatide and semaglutide across weight, glycemic, cardiometabolic, and safety outcomes
Stacking two GLP-1 class compounds (e.g., semaglutide + tirzepatide) is not supported by any clinical trial, is likely to produce additive GI side effects, and has no mechanistic rationale the receptors overlap too much
